1/30
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Analgesic (Pain) Medications
Opioid agonist: (Morphine)
Antidote: Opioid antagonist (naloxone)
Pain
Assessing Pain
Monitoring Pain
Pharmacological vs Non-pharmacological Pain Treatment
Gate Theory of pain
your spinal cord acts like a “gate” that controls how much pain information reaches your brain.
Gate open → more pain signals reach the brain → more pain
Gate closed → fewer pain signals reach the brain → less pain
Types of Pain
Acute- Recent tissue damage or injury
Chronic- constant or intermittent pain that keeps occurring long past the expected healing
Nociceptive- direct stimulus to a pain receptor; characterized by sharp, aching, throbbing that improves as injury heals
examples- cuts, fractures, inflammation, surgery
Somatic (skin, muscles, bones, joins
Visceral (internal organs)
Neuropathic- nerve injury; characterized by tingling, numbness “pins and needles’, shooting sensations
examples: shingles, diabetic neuropathy
Psychogenic- pain that is associated with emotional, psychological, or behavioral stimuli
stomach pain linked to anxiety
Nociceptors
Transduction- injury triggers chemical signals at the site
Transmission- signal travels via nerves to the brain
modulation- brain adjusts the intensity of signal
Perception- person consciously feels the pain
Importance of Assessment of Pain before intervention
OLDCARTS
Onset
Location
Duration
Characteristics
Aggravating factors
Relieving factors
TIming
Severity
pharmacological comfort measures
Heat/Cold therapy, Counter pressure, Walking, Music, Message etc
Controlled substances
Recall role of the DEA
Scheduled medications and the nurse’s responsibilities for administering, monitoring, and wasting
Addiction/Dependency
Abstinence Syndrome (withdraws)
Cramping, hypertension, vomiting, fever, and anxiety
Physically dependent on that substance
Sites of action
Narcotic medication- occupy opioid receptors (agonist) to block pain response
Ergot derivatives- constrict cranial blood vessels, and triptans bind serotonin receptors to cause vasoconstriction
Triptans- bind to serotonin receptors to cause cranial vasoconstriction
Common adverse effects and toxicities associated with narcotics, antimigraine agents
CNS system effects- dizziness, anxiety, impaired mental processes, weakness
Respiratory effects- apnea, suppressed cough reflex
CV (cardiovascular)- (migraine agents): hypertension, chest pressure vasoconstriction
GI effects: Nausea, vomiting, constipation
GU effects: ureteral spasm, urinary retention
Opioid Receptors
Mu receptor-
Analgesia (Pain)
Euphoria (Happiness, excitement)
Respiratory depression
Addiction
Kappa Receptor
Analgesia
Sedation
Dysphoria
Addiction
Delta receptor
Analgesia
Modulates mood
Therapeutic/Pharmacologic Class: Opioid agonists/ Opioid Analgesia
Prototype: morphine
Indications: moderate of severe pain
Mechanism of Action (MOA): Opioid (receptor) agonist; binds to opioid receptor to alter the perception and response to painful stimuli; produces CNS depression (sedative effects)
Side effects: sedation, GI complications (constipation), hypotension, urinary retention
Life threatening: respiratory depression, addiction, abuse, neonatal opioid withdrawal/abstinence syndrome
Nursing Care: Monitor pain, vital signs, respiratory status
Interactions: Avoid using with alcohol or other CNS depressants
Antidote: naloxone (competitive antagonist)-immediate withdrawal (hypertension, tachycardia, agitation)
Patient teaching: increase fluid, fiber intake to prevent contipation
Black Box Warning
Ingestion or alcohol with morphone may increase overdose
Risk of addiction, abuse, misuse
serious, life-threatnening, or fatal respiratory depression
Prolong use during pregnacy may result in neonatal opioid withdrawal/abstinence syndrome
Therapeutic/Pharmacologic Class: Opioid Antagonist
Prototype: Naloxone
Indications: antidote for opioid overdose; reversal of CNS depression and respiratory depression
Mechanism of Action (MOA): competitively blocks the effects of opioids
Side effects: hypertension, ventricular fibrillation, nausea, vomiting
Nursing Care: monitor and treat withdrawal symptoms; naloxone has a shorter duration than most opioids; repair dosing may be needed
Interactions: Avoid using with alcohol or other CNS depressants
Anti-migraine Medications
Triptans (sumatriptan)
Ergot alkaloids (ergotamine)
MIgraine Headaches
Migraine pain (is thought to come from)
trigeminal nerve activation → chemical release → blood vessel dilation → inflammation → pain signals to the brain
May occur with or without an aura
Unilateral, throbbing, severe, worsening with movement, sound, or light
Therapeutic/Pharmacologic Class: 5-HT1 Agonosits (Triptans)
Prototype: Sumatriptan
Indications: migraine and cluster headaches
Mechanism of Action (MOA): intracranial vasoconstriction; acts as an agonist at 5HT1 (a serotonin) receptor sites in intracranial blood vessels and sensory trigeminal nerves
Side effects: dizziness/vertigo, warm tingling sensation
Contraindications: peripheral vascular disease, coronary artery disease, uncontrolled hypertension
Nursing Care: Vascular medication- assess/monitor for signs that vasoconstriction is a problem (linked to peripheral ischemia)
Interactions: antidepressants that are 5-HT1 agonist- may lead to serotonin syndrome
Patient teaching: use during a migraine as symptoms appear; lying down in a dark/quiet room will help; Report palpations or chest pain
Therapeutic/Pharmacologic Class; Ergot Alkaloids
Prototype: ergotamine
Indications: migraine and cluster headaches
Mechanism of action (MOA): intracranial vasoconstriction of dilated blood vessels by stimulating alpha-adrenergic and serotonergic (5-HT0 receptors
Side effects: GI Upset, hypertension
Contraindications: peripheral vascular disease, coronary artery disease, uncontrolled hypertension
Nursing care: Vascular medication- assess/monitor for signs that vasoconstriction is a problem (linked to peripheral ischemia)
Interactions: Interactions may occur with serotinergic antidepressants- increase the risk for serotonin syndrome
Patient teaching: report palpations or chest pain
Serotonin Syndrome
Mild to Moderate
agitation, tremor, sweating, confusion, diarrhea
Resolved with stopping medication and supportive care
Severe
Hyperthermia
Severe muscle rigidity
Seizures
Dangerous blood pressure/heart rate
Multi-organ failure
Death
Triptans vs Ergot Alkaloids
Triptans
new medication with more specific action
better safety profile
Route: oral, nasal, subcutaneous
Ergot alkaloids
reserved for patients that do not response to triptans
Have longer lasting migraines (half-line is longer)
Parenteral (IV) options for impatient use
Alternative/Integrative substances for pain
Cannabis
varying legality by state
Medial Marijuana terminology is used when referring to the treatment of manifestations of illness or other conditions using the whole, unprocessed marijuana plant or the basic extracts
Routes- inhalation, tropical, ingestion
schedule 1 substance under federal law; natural form is not FDA-approved; state medical programs vary
Current legislature may change to a scheduled 3 substance
Not recognized by the FDA- two FDA synthetic derivatives are recognized
Cannabis
Reason for use
cachexia
chemotherapy related nausea and vomiting
Pain
Neuropathies
Spasticity
Adverse effects
increased in heart rate
increased appetite
sleepiness, dizziness
decreased blood pressure
Hallucinations
Dependencies
Anti-inflammatory
Corticosteroids (prednisone)
Salicylates (aspirin)
NSAIDs (Ibuprofen)
COX-2 Inhibitors (celecoxib)
Acetaminophen
Cyclooxygenase Enzymes
the enzyme responsible for converting arachidonic acid in prostaglandins which are chemical messengers involved in pain, inflammation, fever, and normal body function
Therapeutic/Pharmacologic Class: corticosteroids/glucocorticoids
Prototype: Prednisone
Indications: treats inflammatory illness/ disorders or a replacement for patients who do not naturally make enough of the naturally occurring hormone (adrenal insufficiency)
Mechanism of Action (MOA) decrease inflammation, suppresses immune response by inhibitng the release of arachidonic acid
Side effects: bone loss, weight gain/ fluid retention, hyperglycemia, hypokalemia, infection, peptic ulcer disease, adrenal gland suppression, delayed would healing, insomnia
Nursing care: do not discontinue medication suddenly. Monitor infections
Patient teaching: do not stop medication suddenly; taper off
If given too much corticosteroids
Addisons disease, Cushing disease
Therapeutic/Pharmacologic Class: Salicylates (antipyretic; nonopioid analgesic)
Prototype: Aspirin
Indications: treats inflammatory illness/disorders; mild to moderate pain, and fever. Prophylaxis of
transient ischemic attacks (TIAs) and myocardial infarction (MI)
Mechanism of Action (MOA): inhibits the production of prostaglandins and decreases platelet
aggregation
Side effects: bleeding (blood thinning properties), GI bleeding, GI upset, rash
Salicylism- tinnitus (ringing in ears), difficulty hearing (cranial nerve VIII), vomiting, diarrhea,
respiratory alkalosis, dizziness, confusion
Salicylate toxicity- Hyperpnea, tachypnea, hemorrhage, excitement, confusion, pulmonary edema,
metabolic acidosis, respiratory, cardiac, or renal failure
Contraindications: Avoid in pregnancy unless specifically prescribed, children, PUD, bleeding
disorders
Nursing Care: Do not discontinue medication suddenly. Monitor for infections, PUD.
Patient Teaching: take with food or milk to prevent GI upset, report tinnitus, avoid taking NSAIDs
with this, do not give to < 16 yrs of age (Reye’s Syndrome)
Reye’s syndrome
occurs when aspirin interacts with a viral infection, such as influenza or chickenpox
believed that aspirin interferes with the body's ability to process fatty acids in the liver
This leads to an accumulation of fat in the liver and brain, which can cause swelling and damage
NSAID (Nonsteroidal Anti-inflammatory drugs)
Not as many side effects as corticosteroids
very commonly used
all have some level of cardiovascular, gastrointestinal, clotting, and sodium/fluid retention capabilities
Therapeutic/Pharmacologic Class: nonsteroidal anti-inflammatory agents (NSAIDs)
Prototype: ibuprofen
Indications: treatment of mild-to-moderate musculoskeletal pain or dysmenorrhea. Treatment of
inflammatory disorders, fever, pain in adults and children
Mechanism of Action: inhibits prostaglandin synthesis by blocking/inhibiting COX-1 and
COX-2; analgesia by decreasing inflammation
Side effects: GI Upset, nephrotoxicity
Contraindications: pregnancy, PUD, bleeding disorders.
Nursing Care: GI risk (bleeding ulcers, perforation)
Patient Teaching: alcohol increases stomach irritation; may cause drowsiness/dizziness report
dark or red stools
Therapeutic/Pharmacologic Class: cyclooxygenase-2 (COX-2) inhibitor
Prototype: Celecoxib
Indications: relieves signs and symptoms of osteoarthritis synthesis by inhibiting COX-2 with no inhibition of COX-1; analgesia by decreasing inflammation
Side effects: Monitor stools for bleeding, skin for rash (Stevens-Johnson syndrome)
Contraindications: allergies to NSAIDs or sulfonamides
Nursing Care: Linked to cardiovascular thrombotic events (MI, strokes) GI risk (bleeding ulcers,
perforation)
Patient teaching -do not take if HTN or heart failure (HF), Stomach Ulcers or GI bleeding,
Report rash, jaundice/flu-like symptoms